220 results on '"Ortolani, Paolo"'
Search Results
2. Cylinder Head Insulation Plate, Design, Analysis and Testing for an Extreme High Efficiency Internal Combustion Engine
3. New Cam Profile Design Approach, Analysis and Testing for Extreme High Efficiency Internal Combustion Engine Development
4. Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes
5. Sex-Related Outcomes in Elderly Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome: Insights From the Italian Elderly ACS Study
6. Long-Term Outcomes and Causes of Death After Acute Coronary Syndrome in Patients in the Bologna, Italy, Area
7. Reactive follicular lymphoid infiltrate: A new condition to exclude in patients with PET positivity inside the heart
8. Piston Concept, Design and Testing for Extreme High Efficiency Internal Combustion Engine Development
9. Drug Eluting and Bare Metal Stents in People with and without Diabetes: Collaborative Network Meta-Analysis
10. Off-Hour Primary Percutaneous Coronary Angioplasty Does Not Affect Outcome of Patients With ST-Segment Elevation Acute Myocardial Infarction Treated Within a Regional Network for Reperfusion: The REAL (Registro Regionale Angioplastiche dell'Emilia-Romagna) Registry
11. Long-term clinical outcomes after drug eluting stent implantation in women with de novo coronary lesions: Results from the REAL (REgistro Regionale AngiopLastiche Emilia-Romagna) multicenter registry
12. Short- and Long-Term Prognostic Significance of ST-Segment Elevation in Lead aVR in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
13. A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study
14. A Simple Multiparametric Score System to Predict In-Hospital Mortality of COVID-19 Patients
15. Recent temporal trends for first-time hospitalization for acute myocardial infarction. Treatment patterns and clinical outcome in a large cohort study
16. Usefulness of Prehospital Triage in Patients With Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
17. Clinical comparison of “normal-hours” vs “off-hours” percutaneous coronary interventions for ST-elevation myocardial infarction
18. Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry)
19. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement
20. Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: Results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry
21. Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study
22. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network
23. Effect of Sirolimus-Eluting Stent in Diabetic Patients With Small Coronary Arteries (A SES-SMART Substudy)
24. Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network
25. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention
26. Randomized Comparative Trial of a Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Sirolimus-Eluting Stent for Coronary Revascularization
27. Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction
28. Homocysteine-Lowering Therapy and Early Progression of Transplant Vasculopathy: A Prospective, Randomized, IVUS-Based Study
29. 32P Brachytherapy in the Treatment of Complex Cypher In-Stent Restenosis
30. Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices
31. Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis
32. Efficacia a lungo termine della brachiterapia endocoronarica beta (32P) nel trattamento delle ristenosi intrastent ad elevato rischio. Risultati prospettici di un registro monocentrico
33. Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices.
34. Persistence of high events rate following STE vs NSTE acute coronary syndrome in the contemporary era: 5-years outcome in a large real world registry
35. Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute Coronary Syndromes
36. Peripheral arterial disease and long-term mortality following acute coronary syndromes: insights from a large registry of unselected patients
37. Adherence to agents acting on the renin–angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study
38. Association of bleeding, mortality and sex in acute coronary syndromes
39. False Positive Coronary Angiography Activation in a Primary Coronary Angioplasty Network: Does Direct Ambulance-based Access Influence The Prevalence Rate?
40. Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome
41. Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention
42. Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore
43. Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft
44. Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions
45. Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy
46. Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry
47. Reactive follicular lymphoid infiltrate: A new condition to exclude in patients with PET positivity inside the heart
48. Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions
49. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors
50. What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.